Changes to Medicaid, such as the addition of work requirements and funding cuts, could significantly impact hospitals and community-based health plans, according to experts.
These changes could lead to a reduction in coverage, increased uncompensated care for hospitals and financial strain on insurers that primarily serve Medicaid enrollees.
Gabe Scott, a partner at K&L Gates Health Care Group, shared that work requirements have historically led to a decline in Medicaid enrollment.
When low-income adults lose coverage, they often delay or avoid seeking medical care.
“When low-income adults don’t have healthcare coverage, that often means they’re not seeking care,” Scott said.
This can result in more emergency room visits, which are costly and often go unreimbursed, shifting more financial responsibility onto hospitals.
Without access to preventive care, untreated conditions can escalate, leading to higher long-term healthcare costs.
Beyond work requirements, Medicaid funding cuts could create additional challenges for health plans that serve vulnerable populations, according to Jennifer McGuigan Babcock, senior vice president for Medicaid policy at the Association for Community Affiliated Plans (ACAP).
Babcock shared that many of ACAP’s member organizations are nonprofit, community-based insurers that operate exclusively in Medicaid.
Because they typically serve a single state or region, they lack the flexibility of larger insurers to balance out financial losses by expanding into other markets.
Babcock warned that if Medicaid faces large-scale budget reductions, these community-based plans could struggle to stay financially stable.
“If cuts to Medicaid do equal hundreds of billions of dollars, I am very fearful that the community-based plans will be drastically harmed,” she said.
Although, she hopes they will not be forced out of business, as they could potentially see reduced enrollment and funding shortfalls.
In addition, states may face difficulties in maintaining reimbursement rates for Medicaid services, she said.
The combined impact of work requirements and funding cuts could create a challenging environment for both healthcare providers and patients.
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
March 20th 2025Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells genetically engineered to produce specific therapeutic proteins. It will be available in June 2025.
Read More